These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31260413)

  • 1. Low-Dose Intrathecal Ziconotide for Spasticity From Primary Lateral Sclerosis: A Case Report.
    Zhu X; Kohan LR; Goldstein RB
    A A Pract; 2019 Jul; 13(1):31-33. PubMed ID: 31260413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal ziconotide and baclofen provide pain relief in seven patients with neuropathic pain and spasticity: case reports.
    Saulino M; Burton AW; Danyo DA; Frost S; Glanzer J; Solanki DR
    Eur J Phys Rehabil Med; 2009 Mar; 45(1):61-7. PubMed ID: 19156022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal baclofen for spasticity in primary lateral sclerosis.
    Milano JB; Neto MC; Hunhevicz SC; Arruda WO; Ramina R; Barros E
    J Neurol; 2005 Jun; 252(6):740-1. PubMed ID: 15789133
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of intrathecal baclofen on muscle co-contraction in children with spasticity of cerebral origin.
    Sgouros S; Seri S
    Pediatr Neurosurg; 2002 Nov; 37(5):225-30. PubMed ID: 12411712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of intrathecal baclofen pump in primary lateral sclerosis.
    Zubair AS; Raymond M; Patwa HS
    J Neurol Sci; 2021 Jan; 420():117227. PubMed ID: 33239209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ziconotide for the treatment of severe spasticity after spinal cord injury.
    Ridgeway B; Wallace M; Gerayli A
    Pain; 2000 Mar; 85(1-2):287-9. PubMed ID: 10692630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal baclofen for muscle spasticity and pain--two case reports.
    Al Khudhairi D; Rababa A; Saddiqui MN
    Middle East J Anaesthesiol; 2006 Jun; 18(5):971-6. PubMed ID: 17094537
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of intrathecal baclofen for treatment of spasticity in amyotrophic lateral sclerosis.
    Marquardt G; Seifert V
    J Neurol Neurosurg Psychiatry; 2002 Feb; 72(2):275-6. PubMed ID: 11796788
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of intrathecal baclofen delivery in the management of severe spasticity in upper motor neuron syndrome.
    Rietman JS; Geertzen JH
    Acta Neurochir Suppl; 2007; 97(Pt 1):205-11. PubMed ID: 17691378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal Therapies.
    Saulino M
    Phys Med Rehabil Clin N Am; 2018 Aug; 29(3):537-551. PubMed ID: 30626514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ziconotide combination intrathecal therapy: rationale and evidence.
    Wallace MS; Rauck RL; Deer T
    Clin J Pain; 2010 Sep; 26(7):635-44. PubMed ID: 20639730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of intrathecal baclofen for treatment of severe spasticity in selected patients with motor neuron disease.
    Bethoux F; Boulis N; McClelland S; Willis MA; Hussain M; Machado A; Mychkovsky L; Stough D; Sutliff M; Pioro EP
    Neurorehabil Neural Repair; 2013; 27(9):828-33. PubMed ID: 23884016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of severe spasticity treatment with intrathecal Baclofen in multiple sclerosis patients: Long term follow-up.
    Stampacchia G; Gerini A; Mazzoleni S
    NeuroRehabilitation; 2016 Apr; 38(4):385-93. PubMed ID: 27061166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal baclofen for intractable spasticity in amyotrophic lateral sclerosis.
    Marquardt G; Lorenz R
    J Neurol; 1999 Jul; 246(7):619-20. PubMed ID: 10463370
    [No Abstract]   [Full Text] [Related]  

  • 15. Intrathecal baclofen for treatment of spasticity of multiple sclerosis patients.
    Ben Smail D; Peskine A; Roche N; Mailhan L; Thiébaut I; Bussel B
    Mult Scler; 2006 Feb; 12(1):101-3. PubMed ID: 16459726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial.
    Staats PS; Yearwood T; Charapata SG; Presley RW; Wallace MS; Byas-Smith M; Fisher R; Bryce DA; Mangieri EA; Luther RR; Mayo M; McGuire D; Ellis D
    JAMA; 2004 Jan; 291(1):63-70. PubMed ID: 14709577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ziconotide--a novel neuron-specific calcium channel blocker for the intrathecal treatment of severe chronic pain--a short review.
    Klotz U
    Int J Clin Pharmacol Ther; 2006 Oct; 44(10):478-83. PubMed ID: 17063978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An introduction to trialing intrathecal baclofen in patients with hemiparetic spasticity: a description of 3 cases.
    Harned ME; Salles SS; Grider JS
    Pain Physician; 2011; 14(5):483-9. PubMed ID: 21927053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of spasticity related to multiple sclerosis with intrathecal baclofen: a long-term follow-up.
    Rekand T; Grønning M
    J Rehabil Med; 2011 May; 43(6):511-4. PubMed ID: 21533331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecal baclofen therapy in patients with severe spasticity.
    Marra GA; D'Aleo G; Di Bella P; Bramanti P
    Acta Neurochir Suppl; 2007; 97(Pt 1):173-80. PubMed ID: 17691373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.